Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib in Advanced Waldenström Macroglobulinemia
NCT00777738Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2008
- Primary completion
- Aug 2012
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in Waldenström macroglobulinemia (WM), sponsored by Assistance publique - Hôpitaux de Paris. Started Oct 2008; status: completed.
02
Drugs
bortezomib
03
Conditions
Waldenström macroglobulinemia (WM)
Beyond the preview
Go deeper on NCT00777738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00777738.